Nature of early appearing, carcinogen-induced liver lesions resistant to iron accumulation

Journal of the National Cancer Institute

Volumn 57, Issue 1, 1976, Pages 157-165

  Williams, Gary M ^a,b   Klaiber, Marianne ^a,c   Parker, Sally E ^a   Farber, Emmanuel ^a,d  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Naylor Dana Institute for Disease Prevention   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; DIMETHYLNITROSAMINE; IRON; N (2 FLUORENYL)ACETAMIDE;

CARCINOGENESIS; CYTOLOGY; HISTOCHEMISTRY; HYPERPLASTIC NODULE; IRON KINETICS; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER HEMOSIDEROSIS; LIVER INJURY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; RAT; THEORETICAL STUDY;

2-ACETYLAMINOFLUORENE; ANIMAL; DIMETHYLNITROSAMINE; HYPERPLASIA; IRON; LIVER NEOPLASMS; MALE; MITOSIS; NEOPLASMS, EXPERIMENTAL; PRECANCEROUS CONDITIONS; RATS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0017111857     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/57.1.157     Document Type: Article

References (32)

1. Firminger HI: Histopathology of carcinogenesis and tumors of the liver in rats. J Natl Cancer Inst 15:1427-1442, 1955
2. Reuber MD: Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluo-renyldiacetamide. J Natl Cancer Inst 34:697-724, 1965
3. Kitagawa T: Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2-fluorenyIacetamide. Gann 62:207-216, 1971
4. Laws JO: Tissue regeneration and tumour development. Br J Cancer 13:669-674, 1959
5. Bannasch P: The cytoplasm of hepatocytes during carcinogenesis. In Recent Results in Cancer Research, (Rentchnik P, ed.), vol 19. New York, Springer-Verlag, 1968, pp 18-48
6. Rabes HM, Scholze P, Jantsch B: Growth kinetics of diethylni-trosamine-induced, enzyme-deficient “preneoplastic” liver cell populations in vivo and in vitro. Cancer Res 32:2577-2586, 1972
7. Scherer E, Hoffman M, Emmelot P, et al: Quantitative study on foci of altered liver cells induced in the rat by a single dose of diethylnitrosamine and partial hepatectomy. J Natl Cancer Inst 49:93-106, 1972
8. Williams GM, Yamamoto RS: Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hy-droxyquinoline-induced siderosis. J Natl Cancer Inst 49:685692, 1972
9. Kroes R, Williams GM, Weisburger JH: Early appearance of serum a-fetoprotein as a function of dosage of various hepato-carcinogens. Cancer Res 33:613-617, 1973
10. Rabes H, Hartenstein R, Scholze P: Specific stage of cellular response to homeostatic control during diethylnitrosamine-induced liver carcinogenesis. Experientia 26:1356-1359, 1970
11. Scherer E, Hoffmann M: Probable clonal genesis of cellular islands induced in rat liver by diethylnitrosamine. Eur J Cancer 7:369-371, 1971
12. Yamamoto RS, Williams GM, Frankell HH, et al: 8-Hy-droxyquinoline: Chronic toxicity and effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol Appl Pharmacol 19:687-698, 1971
13. Higgins GM, Anderson RM: Experimental pathology of the liver; restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12:186-202, 1931
14. Gomori G: Microtechnical demonstration of iron, a criticism of its methods. Am J Pathol 12:655-663, 1936
15. McManus JF: Histological demonstration of mucin after periodic acid. Nature 158:202, 1946
16. Rappaport AM: Liver architecture and microcirculation. In Alcoholic Liver Pathology (Khana JM, Iscoll Y, Kalant H, eds.). Toronto, Addiction Research Foundation, 1975, pp 43-67
17. Maini MM, Stich HF: Chromosomes of tumor cells. III. Unre sponsiveness of precancerous hepatic tissues and hepatomas to a mitotic stimulus. J Natl Cancer Inst 28:753-762, 1962
18. Kitagawa T: Responsiveness of hyperplastic lesions and hepatomas to partial hepatectomy. Gann 62:217-224, 1971
19. Farber E: The biochemical pathology of liver carcinogenesis. In Liver Cell Cancer (Warwick GP, Cameron HM, Linsell CA, eds.). Amsterdam, Elsevier. In press
20. Gravela E, Feo F, Canuto RA, et al: Functional and structural alterations of liver ergastoplasmic membranes during DL-ethio-nine hepatocarcinogenesis. Cancer Res 35:3041-3047, 1975
21. Miller JA, Cramer JW, Miller EC: The N-and ring-hydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. Cancer Res 20:950-962, 1960
22. Arrhenius E: Effects on hepatic microsomal N-and C-oxygenation of aromatic amines by in vivo corticosteroid or aminoflu-orene treatment, diet or stress. Cancer Res 28:264-273, 1968
23. Haddow A: Cellular inhibition and the origin of cancer. Acta UnInt Contra Cancr 3:342-352, 1938
24. Vasiliev JM, Guelstein VI: Sensitivity of normal and neoplastic cells to the damaging action of carcinogenic substances: A review. J Natl Cancer Inst 31:1123-1143, 1963
25. Goldfarb S, Zak FG: Role of injury and hyperplasia in the induction of hepatocellular carcinoma. JAMA 178:729-731, 1961
26. Pound AW: Carcinogenesis and cell proliferation. NZ Med J 67:88-99, 1968
27. Warwick GP: Effect of the cell cycle on carcinogenesis. Fed Proc 30:1760-1765, 1971
28. Craddock VM: Liver carcinomas induced in rats by a single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst 47:889-907, 1971
29. Farber E, Ichinose H: On the origin of malignant cells in experimental liver cancer. Acta Un Int Contra Cancr 15:152-153, 1959
30. Farber E: Ethionine carcinogenesis. Adv Cancer Res 7:383-474, 1963
31. Weisburger JH, Yamamoto RS, Williams GM, et al: On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res 32:491, 1972
32. Farber E: Hyperplastic liver nodules. Methods Cancer Res 7:345-375, 1973